Characteristics | Current | Last year | P valuea |
---|---|---|---|
No. of patients | 9 | 9 | Â |
No. of aneurysms | 10 | 10 | Â |
Sex (male) | 5 (55.6) | 4 (44.4) | > 0.99 |
Age, years | 50.11 ± 9.3 | 45.3 ± 11.3 | 0.342 |
Admission stratification | |||
 Normal patient | 6 (66.7) |  |  |
 Mild suspected patient | 3 (33.3) |  |  |
 Suspected patient | 0 (0.0) |  |  |
 Confirmed patient | 0 (0.0) |  |  |
COVID-19 NAT (n = 2) (negative) | 2 (100.0) | Â | Â |
False negative COVID-19 NAT | 0 (0.0) | Â | Â |
Location of responsible aneurysm | |||
 ACoA | 3 (33.3) | 3 (33.3) | 0.842 |
 PCoA | 3 (33.3) | 2 (22.2) | |
 ACA | 0 (0.0) | 0 (0.0) | |
 MCA | 3 (33.3) | 4 (44.4) | |
 Others | 0 (0.0) | 0 (0.0) | |
Fisher grade | 3.0 ± 1.2 | 2.9 ± 1.1 | 0.839 |
Modified Fisher grade | 3.2 ± 1.0 | 2.7 ± 1.2 | 0.302 |
Hunt-Hess grade | 2.2 ± 0.4 | 2.2 ± 0.7 | > 0.99 |
WFNS grade | 2.4 ± 0.9 | 2.6 ± 1.2 | 0.819 |
GCS | 12.6 ± 1.8 | 12.3 ± 2.3 | 0.825 |
Duration between rupture and craniotomy, h | 56.9 ± 52.8 | 56.2 ± 60.5 | 0.980 |
Duration between admission and craniotomy, h | 35.6 ± 15.3 | 31.9 ± 12.3 | 0.577 |
Preoperative adverse events during hospitalization | |||
 Rebleeding | 0 (0.0) | 0 (0.0) | > 0.99 |
 Infarction | 0 (0.0) | 0 (0.0) | > 0.99 |
 Epilepsy | 0 (0.0) | 0 (0.0) | > 0.99 |
Duration of surgery, h | 3.7 ± 1.1 | 4.9 ± 2.9 | 0.264 |
Intraoperative blood loss, ml | 188.9 ± 126.9 | 266.7 ± 188.7 | 0.320 |
Mean hospital LOS, days | 17.4 ± 13.9 | 17.9 ± 9.0 | 0.937 |
Hospitalization cost, dollarsb | 17,354.9 ± 12,110.1 | 13,147.1 ± 4200.9 | 0.339 |
Postoperative complications | |||
 Postoperative hemorrhage | 0 (0.0) | 0 (0.0) | > 0.99 |
 Postoperative DCI | 4 (44.4) | 4 (44.4) | > 0.99 |
 Postoperative DVT | 3 (33.3) | 1 (11.1) | > 0.99 |
 Postoperative intracranial infection | 2 (22.2) | 2 (22.2) | > 0.99 |
Discharge mRS score | |||
 Mean | 1.8 ± 1.7 | 2.0 ± 1.7 | 0.788 |
 0–2 | 7 (77.8) | 6 (66.7) | > 0.99 |
 3–6 | 2 (22.2) | 3 (33.3) |